Simvastatin activates single skeletal RyR1 channels but exerts more complex regulation of the cardiac RyR2 isoform
Statins are amongst the most widely prescribed drugs for those at risk of cardiovascular disease, lowering cholesterol levels by inhibiting 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase. Although effective in prevention of cardiovascular disease, statin use is associated with muscle weak...
Những tác giả chính: | Venturi, E, Lindsay, C, Lotteau, S, Yang, Z, Steer, E, Witschas, K, Wilson, A, Wickens, J, Russell, A, Steele, D, Calaghan, S, Sitsapesan, R |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
Wiley
2017
|
Những quyển sách tương tự
-
Atorvastatin activates skeletal RyR1 channels: towards reducing statin side-effects
Bằng: Lindsay, C, et al.
Được phát hành: (2018) -
Ca2+-calmodulin increases RyR2 open probability yet reduces ryanoid association with RyR2
Bằng: Sigalas, C, et al.
Được phát hành: (2009) -
Impaired ligand regulation of native RyR2 channels in the catecholaminergic polymorphic ventricular tachycardia mutation, RyR2-V2475F(+/−)
Bằng: Wilson, A, et al.
Được phát hành: (2019) -
Statins bind to cardiac ryanodine receptor (RyR2) channels to alter opening frequency
Bằng: Wilson, A, et al.
Được phát hành: (2018) -
Modelling the ATP binding site of RyR2 to rationalise ligand-induced gating behaviour
Bằng: Lindsay, C, et al.
Được phát hành: (2019)